Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo Studies

Area of Science:

• Microbiology
• Photomedicine
• Infectious Diseases

Background:

• Bacterial biofilms are implicated in over 80% of human infections.
• Biofilms exhibit significant drug resistance, complicating treatment.
• Developing novel strategies to combat biofilm infections is crucial.

Purpose of the Study:

• To evaluate the efficacy of antimicrobial blue light (aBL) against Acinetobacter baumannii and Pseudomonas aeruginosa biofilms.
• To assess aBL's effectiveness in both in vitro (microplate) and in vivo (mouse burn wound) models.
• To determine the safety profile of aBL treatment on host tissues.

Main Methods:

• Biofilms of A. baumannii and P. aeruginosa were cultured in microplates and established on mouse burn wounds.
• Biofilms were exposed to antimicrobial blue light (aBL) at a wavelength of 415 nm.
• Bacterial inactivation was quantified by colony-forming units (CFU), and tissue safety was assessed using TUNEL assays.

Main Results:

• aBL significantly reduced CFU counts in both A. baumannii and P. aeruginosa biofilms in vitro.
• In vivo, specific aBL doses effectively inactivated bacterial biofilms in mouse burn wounds at different time points post-infection.
• aBL treatment did not induce apoptosis in irradiated mouse skin, indicating a favorable safety profile.

Conclusions:

• Antimicrobial blue light demonstrates potent antimicrobial activity against A. baumannii and P. aeruginosa biofilms.
• aBL presents a viable therapeutic option for treating infections associated with these problematic biofilms.
• Further research into aBL as a clinical intervention for biofilm-related infections is warranted.